Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0018799 (heart disease)
 34,133 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

His bundle electrograms were performed on 10 patients with organic heart disease. Six patients had had a recent myocardial infarction. Recordings were made at various rates utilizing right atrial pacing. Nitroglycerin, 1/150 gr, was administered to all 10 subjects, and the P-A, A-H, H-Q and H-S intervals were determined before, and immediately after the disappearance of the sublingually administered nitroglycerin. A significant decrease in the A-H interval occurred with negligible effects on the P-A, H-Q and H-S intervals. At the atrial pacing rate of 100/min, the average A-H interval fell from the control value of 152 msec to 129 msec after the administration of nitroglycerin (p less than 0.02); at the pacing rate of 130/min, the A-H interval decreased from 194 to 133 msec (p less 0.05). Second degree heart block occurred at higher pacing rates in six patients after nitroglycerin administration as compared to the control value. The average postsuppression sinoatrial recovery time control value of 1,083 msec decreased to 906 msec after nitroglycerin administration (p less than 0.01). These findings demonstrate that nitroglycerin can improve conduction through the A-V node.
 ...
PMID:The effect of nitroglycerin on atrioventricular conduction in man. 82 58

According to data obtained from the Japanese Dental Society and from Osaka University Dental Hospital, systemic complications during dental treatment fall into one of two categories; one set of complications has no relationship to underlying disease, and the other is related to disease status. In the former category there are the hyperventilation syndrome and neurogenic shock and in the latter, cerebrovascular accidents and heart disease are prominent, particularly in the geriatric patient. The pathophysiology of neurogenic shock and hyperventilation syndrome is explained. The influences of epinephrine and norepinephrine on the young healthy adult, the older healthy adult and on the patient with cardiac disease have been investigated by means of the Systolic Time Interval (STI) method and echocardiography. In the evaluation of likely haemodynamic changes during dental treatment, examination of the fundus oculi is recommended. Glyceryl trinitrate infusion, sublingual glyceryl trinitrate and isosorbide dinitrate tape have been introduced as agents for blood pressure control during dental treatment. From the dentists' standpoint, the evaluation of the patient with various cardiovascular disorders is described.
 ...
PMID:Systemic complications and their management during dental treatment. 252 91

Nitroglycerin ointment (NTGO) was applied to the precordial area in 88 patients with heart failure arising from acute myocardial infarction (AMI) or other types of heart disease, and its effects on hemodynamic parameters were determined. After NTGO was applied, patients' systolic blood pressure (P less than 0.001), double product (heart rate X systolic pressure, P less than 0.001), pulmonary capillary wedge pressure (P less than 0.001), and systemic vascular resistance (P less than 0.001) decreased significantly. These changes began 30 to 60 minutes after NTGO was applied and lasted two to six hours. Based on these hemodynamic changes, we conclude that NTGO is beneficial for patients with heart failure due to AMI or other heart disease.
 ...
PMID:Multicenter studies of 2% nitroglycerin ointment in patients with heart failure. 643 84

Nitroglycerin (GTN) has been used to treat heart disease for many years. It is generally believed that GTN is a prodrug; however, the mechanism for GTN bioactivation remains unknown. Recent studies, using hepatic microsomes, have suggested the involvement of cytochrome P450 3A (CYP3A) in GTN biotransformation. Here, we used an animal model to test the hypothesis that aortic CYP3A plays a role in the bioactivation of GTN in vivo. Ketoconazole (KCZ), a potent CYP3A inhibitor, was given to rats (50 mg/kg i.p.) 1 hr before a bolus dose of GTN (2 mg/rat i.v.). KCZ decreased GTN-induced cGMP (cyclic guanosine monophosphate) levels by 20 to 30% (P < .05), without affecting basal or S-nitroso, N-acetyl penicillamine-induced levels of cGMP. When rats received dexamethasone (DEX, 30 mg/kg, 4 days i.p.), a strong CYP3A inducer, they exhibited a significant (approximately 50%) higher cGMP response to GTN than the control group. When rats received the combination treatment of both DEX and KCZ, they responded to GTN to the same extent as control rats. Although the effect of KCZ on aortic CYP3A activity cannot be detected (activity in control rats is below the detection limit), KCZ markedly inhibited CYP3A activity in rat livers (2.02 +/- 0.04 vs. 0.31 +/- 0.04 nmol/mg prot/min, P < .05, in control vs. KCZ-treated rats, respectively) and in DEX pretreated rat aorta (0.145 +/- 0.036 vs. 0.042 +/- 0.037 nmol/mg prot/min, P < .05, in rats treated with DEX alone vs. rats treated with both DEX and KCZ, respectively). KCZ did not elicit an effect on aortic glutathione S-transferases, another major metabolic enzyme responsible for GTN biotransformation. DEX enhanced the aortic GST mu activity by 3-fold. However, the activity of GST in aorta did not correlate with the cGMP response to GTN. In conclusion, our results demonstrate that CYP3A activity in aorta is correlated with GTN bioactivation in vivo, but the contribution of this enzyme to overall GTN bioactivation is limited.
 ...
PMID:Investigation of aortic CYP3A bioactivation of nitroglycerin in vivo. 919 Aug 88